Posts by Naomi J. Patel, MD
-
Anti-CD20 Monoclonal Antibody Therapy for Immune-mediated Diseases Increases Risk of Death from COVID-19
Zachary S. Wallace, MD, MSc, Naomi J. Patel, MD, and colleagues determined retrospectively that the risk of death from COVID-19 is twice as high in patients who use anti-CD20 monoclonal antibodies for the treatment of immune-mediated diseases versus COVID-19 patients in the general population.
Biography
Naomi J. Patel, MD, is a physician in the Rheumatology Unit in the Department of Medicine at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School.
Rheumatology, Allergy and Immunology
The Division of Rheumatology, Allergy and Immunology at Massachusetts General Hospital provides leading-edge treatment and transformative care to patients with rheumatic disease and autoimmune conditions.